English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Patient Daily
| Apr 10, 2026
Temporary heart pump before PCI shows no significant benefit
Patient Daily
| Apr 10, 2026
Intensive LDL cholesterol lowering reduces cardiovascular events in heart disease patients
Patient Daily
| Apr 10, 2026
Catheter-based approach improves prognosis in pulmonary embolism patients
Patient Daily
| Apr 10, 2026
Investigational drug lowers angiotensinogen but shows unclear blood pressure benefits
Patient Daily
| Apr 10, 2026
Angioplasty improves symptoms in chronic total coronary occlusion patients
Patient Daily
| Apr 10, 2026
Evolocumab lowers cardiac event risk in high-risk diabetic patients, study shows
Patient Daily
| Apr 10, 2026
Home-delivered DASH diet linked to improved blood pressure in Black adults with hypertension
Patient Daily
| Apr 10, 2026
Novel vFFR method performs similarly to standard coronary assessment in European trial
Trending
Patient Daily
| Apr 7, 2026
ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+
Regulatory
Patient Daily
| Apr 9, 2026
Reason Foundation commentator on vaccine liability: 'Exposing vaccine makers to the machinations of trial lawyers will stymie the development of innovative vaccines'
+
Regulatory
Patient Daily
| Apr 8, 2026
Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'
+
Pharmaceuticals
Patient Daily
| Apr 10, 2026
Researchers identify artemin as marker and target in feline osteoarthritis
« First
«
1
2
3
4
5
…
»
Last »